Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease

(MedPage Today) — HOUSTON — SGLT2 inhibitors may benefit more patients with chronic kidney disease (CKD) than previously thought, two meta-analyses indicate. SGLT2 inhibitors have helped slow the progression of CKD…